Transmyocardial laser revascularization in allograft coronary artery disease

Citations of this article
Mendeley users who have this article in their library.


We used transmyocardial laser revascularization to treat accelerated cardiac allograft atherosclerosis in 2 patients. One patient received transmyocardial laser revascularization as sole therapy, the other as an adjunct to coronary artery bypass grafting. The systolic function improved in both patients, although the patient who had adjunctive transmyocardial laser revascularization died of systemic infection and renal failure on postoperative day 55. The second patient is alive and well 11/2 years after the laser procedure. We discuss 4 other patients who received transmyocardial laser revascularization treatment elsewhere in the United States. Transmyocardial laser revascularization has the potential to become important in the treatment of transplant atherosclerosis. Randomized clinical trials are warranted to assess the efficacy of transmyocardial laser revascularization in this setting. © 1998 by The Society of Thoracic Surgeons.




Frazier, O. H., Kadipasaoglu, K. A., Radovancevic, B., Cihan, H. B., March, R. J., Mirhoseini, M., & Cooley, D. A. (1998). Transmyocardial laser revascularization in allograft coronary artery disease. Annals of Thoracic Surgery, 65(4 SUPPL.), 1138–1141.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free